Cargando…
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
Extra-cellular galectins 1, 3 and 9 (gal-1, −3 and −9) are known to act as soluble immunosuppressive agents in various malignancies. Previous publications have suggested that their expression is dependent on the metabolic status of producing cells and reciprocally that they can influence metabolic p...
Autores principales: | Tran, Bao-Tram Thi, Gelin, Aurore, Durand, Sylvère, Texier, Matthieu, Daste, Amaury, Toullec, Clémence, Benihoud, Karim, Breuskin, Ingrid, Gorphe, Philippe, Garic, Florence, Brenner, Catherine, Le Tourneau, Christophe, Fayette, Jérôme, Niki, Toshiro, David, Muriel, Busson, Pierre, Even, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762837/ https://www.ncbi.nlm.nih.gov/pubmed/36545254 http://dx.doi.org/10.1080/2162402X.2022.2150472 |
Ejemplares similares
-
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
por: Chevalier, Thomas, et al.
Publicado: (2021) -
Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model
por: Baloche, Valentin, et al.
Publicado: (2021) -
Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9
por: Lhuillier, Claire, et al.
Publicado: (2018) -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
por: Gorphe, Philippe, et al.
Publicado: (2022) -
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
por: Veyrat, Mathieu, et al.
Publicado: (2016)